RecruitingNCT07492004

China Monogenic Diabetes Registry


Sponsor

Tianjin Medical University General Hospital

Enrollment

5,000 participants

Start Date

Feb 28, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to: Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution Participants will: * Enroll in the monogenic diabetes registry via mobile application or web-based platform * Undergo molecular genetic testing to establish a definitive diagnosis


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No Interventions for people with maturity onset diabetes of the young, monogenic diabetes, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo Interventions

No Interventions


Locations(1)

Tianjin medical university general hospital

Tianjin, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07492004


Related Trials